AEterna Zentaris Q2 EPS $(0.64) Down From $(0.47) YoY, Sales $2.30M Beat $1.10M Estimate
AEterna Zentaris Q2 EPS $(0.64) Down From $(0.47) YoY, Sales $2.30M Beat $1.10M Estimate
依特鈉Q2每股收益爲$(0.64)，較上年同期$(0.47)下滑，銷售額爲$2.3 million，超過$1.1 million的預估。
AEterna Zentaris (NASDAQ:CSCI) reported quarterly losses of $(0.64) per share. This is a 36.17 percent decrease over losses of $(0.47) per share from the same period last year. The company reported quarterly sales of $2.30 million which beat the analyst consensus estimate of $1.10 million by 109.09 percent. This is a 64.29 percent increase over sales of $1.40 million the same period last year.
依特鈉（NASDAQ:CSCI）報告每股虧損0.64美元，這比去年同期每股虧損0.47美元下降了36.17％。公司報告的季度銷售爲230萬美元，超出分析師的110萬美元預期，增長了109.09％。這比去年同期的銷售額增加了64.29％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間